Scorpion snags a Sanofi vet to lead the way to the clinic; All eyes on eli-cel as bluebird seeks a finance leader — again
Upon taking the helm at precision oncology-focused Scorpion Therapeutics last summer, Axel Hoos told Endpoints News that he had a clear vision of the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
